|
George
Trutza spent 11 years at US Surgical in a number
of senior sales and marketing management roles, including President, Kendall Medical & Surgical Division. As Vice President
of Marketing, George took over the Suture business driving
it to over $200M in sales and successfully laid the foundation
for the integration of the acquisition of Davis&Geck suture
products. Subsequent to Tyco’s acquisition of United
States Surgical George was promoted and spent over two years
at Tyco Healthcare serving as President of the Kendall Medical
& Surgical Division and President of Tyco Healthcare Group
Canada with annual sales of $600M and $150M respectively.
He left Tyco to join Surgicon Inc. a Connecticut based turnaround
minimally invasive medical device company. From there he joined
Accellent, Inc a medical device contract manufacturing company
as EVP & GM of the companies Endo Division, and since
April 2005 has been evaluating opportunities in the spine
area of medical devices.
|
Doug
Redding. Doug has more than 30 years experience in finance and operations, most recently as Chief Operating Officer of VIMAC Ventures, an early-stage venture capital firm with investments in information technology and life sciences. In addition to managing firm operations, Doug spent a substantial portion of his time supporting portfolio company management on planning, budgeting, infrastructure and financing.
Prior to VIMAC, Doug spent 20 years as a founder and senior level executive at several early-stage technology firms, including Software Developers' Company, Cortex Corporation, CenterLine Software and edu.com. He started his career with seven years at Price Waterhouse and is a Certified Public Accountant. Doug holds a BA from Stanford University and attended Cornell and UCLA Graduate Schools of Business.
|